Evommune (EVMN) Current Leases (2024 - 2026)

Evommune (EVMN) has 3 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• Quarterly Current Leases changed N/A year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $242000.0, down 50.31% from the prior year.
• Current Leases climbed to $1.3 million in Q1 2026 per EVMN's latest filing, from $242000.0 in the prior quarter.
• Across five years, Current Leases topped out at $1.3 million in Q1 2026 and bottomed at $160000.0 in Q3 2025.
• The 3-year median for Current Leases is $364500.0 (2024), against an average of $535500.0.
• Peak annual rise in Current Leases reached 50.31% in 2025, while the deepest fall reached 50.31% in 2025.
• Tracing EVMN's Current Leases over 3 years: stood at $487000.0 in 2024, then plunged by 50.31% to $242000.0 in 2025, then jumped by 417.77% to $1.3 million in 2026.
• Per Business Quant, the three latest EVMN Current Leases figures stand at $1.3 million (Q1 2026), $242000.0 (Q4 2025), and $160000.0 (Q3 2025).

Peer Comparison